Natural Alternatives International Inc. reported a decline in financial performance for the three months ended September 30, 2024, compared to the same period in 2023. Net sales decreased by 2% to $33.15 million from $33.97 million, primarily driven by a 5% drop in private-label contract manufacturing sales due to reduced orders from a major customer. However, revenue from patent and trademark licensing increased significantly by 42% to $2.52 million, up from $1.78 million.
The company's gross profit also fell by 28% to $2.26 million, down from $3.14 million, contributing to a net loss of $1.98 million, compared to a net loss of $0.70 million in the prior year, marking an increase in loss of 185%. The loss from operations rose to $1.84 million from $0.54 million, indicating a 238% increase in operational loss. Selling, general, and administrative expenses increased by 11% to approximately $4.0 million, attributed to higher compensation, benefits, and legal fees.
Cash flow from operating activities turned negative, with a net cash usage of $3.44 million compared to a cash inflow of $4.50 million in the previous year. The company reported a decrease in cash and cash equivalents to $10.16 million from $11.98 million at the end of June 2024. Accounts receivable increased slightly to $17.62 million, while inventories rose to $25.93 million.
Strategically, the company extended its lease for its Vista, California manufacturing facility for an additional 10 years and 5 months, which increased its lease liability and Right of Use asset by approximately $25.9 million. The company is also investing around $2.3 million in a solar electrical generating system for the facility, with partial reimbursement from the landlord.
As of September 30, 2024, the company was not in compliance with certain financial covenants related to net income and anticipates continued non-compliance in the upcoming quarters. The company is negotiating a potential revised credit facility with Wells Fargo Bank, which has advised that they will not exercise options under the Credit Agreement while considering the request.
Overall, Natural Alternatives International Inc. is facing challenges in revenue generation and profitability, while also making strategic investments to enhance its operational capabilities.
About NATURAL ALTERNATIVES INTERNATIONAL INC
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.